Top 5 Current Trends in Oregon Addiction Treatment

Where Oregon's recovery system actually stands in 2025

If you're reading this, you've probably already lived through the hardest phone calls a parent can take. You know what a continuum of care is supposed to look like on paper, and you know how often the real thing falls short of the diagram. So let's skip the orientation and talk about what's actually different in Oregon right now.

Three things are true at once. Oregon's overdose deaths dropped 22% in the 12 months ending December 2024, the first sustained decline since fentanyl took hold of the supply ¹. The state's Section 1115 Medicaid waiver is, finally, paying for the kind of continuum that families have been asking about for a decade — residential, intensive outpatient, recovery housing, and care coordination, financed as connected pieces rather than disconnected line items ⁴. And the political ground underneath all of it has shifted, with the 2025 Secretary of State audit concluding that Measure 110 "lacks stability, coordination, and clear results" even as service encounters have grown ¹⁰.

That mix — measurable progress, real financing reform, and unresolved governance — is the system your adult child is entering. It's not the catastrophe some headlines describe, and it's not the breakthrough others claim. It's a system in the middle of getting better at some things while still struggling with bed capacity, workforce, and accountability.

The five trends below are the ones that will most directly shape what post-detox or post-residential care looks like for your family this year. Each one carries a practical implication for how you evaluate a program, not just how you read the news.

Medicaid's 1115 waiver is finally funding a real continuum of care

For years, the gap between detox and durable recovery has been a financing problem dressed up as a clinical one. Your adult child completes a stabilization stay, the discharge planner hands over a list of phone numbers, and the next level of care either has a waitlist or isn't billable in a way that sustains the program offering it. The 1115 waiver is what's quietly closing that gap.

Oregon's Section 1115 SUD Demonstration Waiver, running through 2026, is designed to "build a full continuum of care for Oregon Medicaid members with substance use disorders" ³. That phrase has been on policy documents for years, but the waiver gives it teeth: it authorizes Medicaid payment for residential treatment in IMD settings, intensive outpatient programming, recovery support services, peer-delivered care, and care coordination across those levels ⁴. Before the waiver, federal Medicaid rules effectively blocked payment for residential SUD care in larger facilities, which is why so many private programs operated on a cash or commercial-insurance basis only. Now the same family on the Oregon Health Plan can move from detox to residential to IOP to recovery housing with the financing actually following the person.

The peer-reviewed evidence on this is encouraging, with appropriate caveats. A 2024 study examining states that adopted SUD 1115 waivers found that implementation was associated with increased Medicaid-paid SUD treatment volume and higher rates of medication treatment for opioid use disorder ⁶. The authors note the difficulty of isolating waiver effects from other concurrent policy and market changes, so treat this as a directional finding rather than a clean causal claim. Still, the pattern is what you'd hope to see: when you pay for the full continuum, more people receive evidence-based care, and more of them receive buprenorphine or methadone alongside behavioral treatment.

Here's what the financing change means in practical terms for your family. Intensive outpatient is no longer the orphan tier — the level of care that residential programs hand off to and then lose track of. Under the waiver, IOP is reimbursed as a connected step in a documented continuum, which means the program your adult child enters after residential is supposed to receive a warm handoff, share treatment records, and coordinate medication management. Whether that actually happens depends on the specific providers involved, but the financing is no longer the excuse.

Two things to watch when you're evaluating a program against this backdrop. First, ask directly how the IOP receives referrals from detox and residential partners, and whether they participate in the waiver's care coordination expectations. Second, ask whether they bill the Oregon Health Plan for the full IOP level of care or whether they'll route your adult child to a lower-intensity outpatient track because of reimbursement constraints. The waiver removed that constraint for compliant providers. A program that still treats IOP as a cash-pay-only product is making a business choice, not responding to a financing barrier.

The harder truth: the waiver expires in 2026, and renewal will depend on Oregon meeting milestones around length of stay in residential settings, MOUD access, and continuity of care metrics ³. The continuum you're navigating right now is partially propped up by federal demonstration dollars that have to be re-earned. That's not a reason to lose hope — it's a reason to ask programs how they're positioned for the renewal cycle, because the ones that have built their model around the waiver's expectations are the ones most likely to still be there in three years.

The overdose curve bent — but the reasons matter more than the headline

You've probably seen the headlines. Oregon's overdose deaths fell 22% in the 12 months ending December 2024, according to provisional CDC data tracked by the Oregon Health Authority ¹. That's the first sustained decline since fentanyl reshaped the supply, and it deserves to be acknowledged honestly: fewer families got the call no parent wants. If your own family is still standing in that fear, this matters. It doesn't erase what's happened, but it does mean the curve can move.

Here's the part that should temper the celebration. Nationally, drug overdose deaths fell nearly 24% over a similar window — about 87,000 deaths in the 12 months ending September 2024, down from roughly 114,000 the year before ⁷. Oregon's improvement is tracking the national pattern, not outpacing it. That distinction matters because it changes how you read claims about which specific Oregon policy or program "caused" the decline. Whatever is bending the curve is bigger than any single state intervention, and it's also bigger than any single state's failures.

The likely drivers are layered and partially overlapping. Naloxone is genuinely everywhere now — in schools, libraries, county health offices, and the glove compartments of people who never expected to carry it. Oregon's opioid response strategy explicitly leans into broader naloxone distribution, fentanyl test strips, and public awareness as central tools, alongside treatment expansion ¹⁵. The illicit supply itself has also shifted, with fentanyl concentrations and adulterant patterns changing in ways researchers are still mapping. And the treatment infrastructure that the 1115 waiver is financing has had time to start showing up in the data, even if the causal chain is messy.

What this means for how you read the room. The decline is real, but it is not a finish line, and it is not evidence that the system has solved itself. Oregon's fentanyl overdose death rate was one of the fastest-growing in the country from 2019 to 2023 ¹⁵— the 22% drop is from a peak that was historically high, not from a baseline anyone would call acceptable. If a program markets itself by waving the overdose decline as proof its model works, push harder. Ask what they're measuring at 30, 90, and 365 days post-discharge for their own patients, and whether they track returns to use, not just completions.

For your adult child specifically, the practical takeaway is encouraging without being naive. The environment they're entering treatment in is statistically less lethal than it was 18 months ago, naloxone access has improved across the Pacific Northwest, and the supply-side shifts that have helped drive national declines are also showing up locally. That gives a relapse — should one happen — a marginally better chance of not being fatal. It does not change the fact that recovery still requires structure, honesty, and the kind of step-down care that holds someone steady when the residential walls come down.

Telehealth and hybrid IOP are becoming the working center of post-residential care

Here's the shift that surprised even the clinicians who used to be skeptical: telehealth IOP didn't collapse when the pandemic emergency declarations ended. It got better, and it stayed.

A December 2024 peer-reviewed study of a telehealth-delivered substance use disorder intensive outpatient program reported that nearly 80% of participants remained engaged in the program for 30 days, and 91% attained at least 30 consecutive days of abstinence ¹⁷. Those numbers are striking, and they deserve the scope they came with. This was a single program studied in real-world practice, not a population-level evaluation. Participants self-selected into telehealth care, which means the people who showed up were the people for whom virtual fit. The authors flag the need for further research on longer-term outcomes and potential selection biases ¹⁷. Read the findings as a strong signal that telehealth IOP can work for the right person, not as a guarantee it will work for everyone.

For your adult child, the more useful question isn't "is telehealth IOP effective?" — the literature is increasingly answering that. The question is whether a hybrid model fits the specific transition they're making. Someone stepping out of a 30- or 60-day residential stay has just spent weeks in a high-structure environment. The drop from that container to three outpatient sessions a week, even excellent ones, is the part of the continuum where people most often slip. A hybrid IOP — where some sessions happen in person and others happen on video, where urinalysis is observed at the clinic but check-ins and group can happen from a kitchen table — closes that drop. It lets your adult child re-enter the working world, sleep at home or in a sober living house, and still receive nine to twelve clinical hours a week without driving across Portland for every contact.

The geographic implications matter for families in the Pacific Northwest. Oregon's residential and IOP capacity is heavily concentrated in the Portland metro, with thinner coverage in Central Oregon, the coast, and the eastern counties. A hybrid IOP that accepts patients across the state — and, in many cases, across state lines into parts of Washington — lets an adult child living in Bend or Pendleton receive the same level of care as someone in the city. OHA's own outpatient framework explicitly recognizes that programs may deliver multiple service modalities and combine them within a single clinical episode ¹³. The regulatory architecture is built for this.

What to ask when you're evaluating a hybrid IOP. First, what is the in-person component, and is it required or optional? Programs vary widely. A truly hybrid model has at least one weekly in-person touchpoint for the first phase, not just "you can come in if you want." Second, how are they handling medication management? If your adult child is on buprenorphine or naltrexone, the IOP should either provide MOUD directly or have a documented relationship with a prescriber who's actually responsive — not a referral to a waitlist. Third, what does family involvement look like inside the telehealth structure? The honest answer should include scheduled family sessions, family education modules, and clear communication about what your adult child has consented to share. Telehealth makes family participation logistically easier — you can join a session from your office — but only programs that have built that into the model will offer it without prompting.

One caveat to hold onto. The engagement and abstinence figures from the 2024 study are 30-day metrics. They tell you something real about whether a person stays in care through the riskiest first month after a step-down. They don't tell you what happens at six months or a year, and the authors are explicit about that gap ¹⁷. When a program quotes its own outcomes, ask for the longer windows. Programs serious about their work track returns to use, not just completion of the IOP episode, and they'll tell you what they measure even when the numbers aren't flattering.

Residential bottlenecks are reshaping where adult children actually land

The waitlist conversation is the one nobody warns you about. Your adult child finishes detox on a Friday, the discharge planner says residential is the right next step, and then comes the call to seven facilities and the discovery that the earliest open bed is sixteen days out. Sixteen days is a long time when someone has just gotten through withdrawal.

The June 2024 OHA Behavioral Health Residential+ Facility Study projected Oregon would reach 1,029 mental health residential treatment facility or home beds by the third quarter of 2025, equivalent to 24.29 beds per 100,000 population, with an additional 102 beds identified as possible expansion ⁹. The study focuses on mental health residential capacity, not SUD residential specifically, but the two systems compete for the same workforce, the same licensed buildings, and often the same referral coordinators. When mental health residential is at 24 beds per 100,000, the broader behavioral health continuum your adult child is moving through is squeezed in the same way.

That scarcity has a downstream effect families feel before they understand the cause. Detox stays get compressed because the receiving residential program can't take a transfer for two weeks. Residential stays get shortened because the next admission is already scheduled and the bed has to turn. And the level of care that absorbs the overflow — the place where adult children actually land when the residential math doesn't work — is intensive outpatient.

This is the structural reason IOP has moved from a step-down option to, in many cases, the primary container for early recovery. It isn't always a clinical choice. Sometimes it's the only door that opens on the day your family needs a door to open. The good news is that the financing under the 1115 waiver, combined with the engagement data from telehealth and hybrid models, means a well-run IOP can hold someone through the transition that residential used to handle. The harder news is that this only works when the IOP is genuinely built for post-detox or post-residential acuity — nine to twelve clinical hours a week, MOUD coordination, observed urinalysis, and a stable sober living or recovery housing partner attached.

Recovery housing is the piece that often determines whether the IOP container actually holds. OHA's Behavioral Health Housing and Licensed Capacity Investments Dashboard tracks recovery housing units and residential beds being funded and brought online across the state, with investments distributed unevenly across counties ¹². If your adult child is returning to a living environment where substances were a daily presence — a roommate situation, a family home where another member is actively using, an apartment in a neighborhood that triggers cravings — the IOP clinical hours will not be enough on their own. Ask the program directly which sober living houses they refer to, what the house rules and oversight look like, and whether the program has any formal relationship with the operator or is simply handing over a list.

The outpatient regulatory framework supports this kind of bundled approach. OHA's outpatient program guidance acknowledges that clinics may provide multiple service types — substance use treatment, co-occurring mental health support, problem gambling services — within a single clinical episode, and that programs serving people in the community can combine those modalities ¹³. The infrastructure to deliver wraparound care exists. The question for your family is whether the specific program you're evaluating has built it out, or whether it offers IOP as a standalone product without the housing, medication, and family coordination that make it work for someone stepping down from a higher level of care.

The practical question to ask when residential isn't available on your timeline: what does this IOP look like in its first two weeks for a patient coming directly out of detox? A program that can answer specifically — increased session frequency, paired sober living, MOUD bridge prescribing, daily check-ins, family contact protocols — has built for the bottleneck you're standing in. A program that describes its standard schedule and stops there has not.

Measure 110, HB 4002, and the BHRN reckoning families should track

This is the trend most articles either oversell or dodge. You deserve the honest version.

Measure 110, passed in 2020, redirected cannabis tax revenue into a statewide Behavioral Health Resource Network — county-level grantees providing screenings, assessments, peer support, harm reduction, low-barrier treatment, and transitional housing ¹⁴. The 2025 Secretary of State audit concluded that the program "lacks stability, coordination, and clear results," pointing to inconsistent data, governance churn, and limited evidence of measurable outcomes even as service encounters grew substantially ¹⁰. That finding is real, and it should inform how you read claims about BHRN-funded providers.

The Portland State University research team's final report adds a different layer. After three years of empirical work, the lead researcher concluded their findings offered "little to no support" for claims that Measure 110 caused increases in crime, with drug arrests and most crime categories declining or stable through 2023 ¹¹. Both findings can be true at once. The program didn't drive the crime wave it was blamed for, and it also hasn't yet produced the coordinated, accountable continuum its architects promised. Hold both.

House Bill 4002, signed in 2024, recriminalized personal drug possession as a misdemeanor and created deflection programs designed to route people toward treatment instead of jail. For your family, this changes the referral landscape in ways worth understanding. If your adult child is contacted by law enforcement in Multnomah, Washington, or another participating county, the deflection pathway can connect them to a BHRN provider or a treatment assessment within hours rather than days. That's a meaningful shift from the post-Measure 110 period, when the citation-and-hotline model rarely produced engagement. It's also uneven across counties — some have built robust deflection infrastructure, others haven't.

One governance change worth marking on your calendar: after January 1, 2026, the Measure 110 Oversight and Accountability Council shifts from a decision-making body to an advisory role, with OHA assuming direct authority over BHRN funding decisions ¹⁴. That consolidation responds to the audit's coordination findings, but it also means the providers your adult child may encounter through the BHRN network are operating under governance that's actively being rewritten.

What this means practically. The fentanyl-driven adjustments OHA made in late 2023 — broader naloxone distribution, fentanyl test strip access, and enhanced outreach to people not yet in treatment — remain in place and are being absorbed into the BHRN model rather than competing with it ¹⁵. If a program you're evaluating is plugged into the BHRN as a grantee, ask what that funding supports, how stable it is through the 2026 transition, and whether their clinical services rely on it or simply complement it. Programs whose core treatment isn't dependent on BHRN dollars are better positioned for whatever the next governance cycle brings.

What this means when you're choosing care for your adult child

Pull these five threads together and a working checklist emerges. You're looking for a program that bills the Oregon Health Plan for the full IOP level of care under the 1115 waiver, coordinates warm handoffs from detox and residential partners, and can show you its own 90- and 365-day outcomes — not just the field's improving overdose backdrop ². You're looking for hybrid delivery that fits your adult child's geography in Portland, Central Oregon, or further out, with at least one weekly in-person touchpoint in the first phase. You're looking for MOUD coordination that doesn't end at a referral, a real sober living partner the program can name, and family sessions built into the schedule rather than tacked on.

Hold the harder things too. Recovery still asks for honesty when a session is missed, structure when motivation dips, and accountability when relapse happens — because relapse, when it happens, is information, not failure. The system around your family is getting better at catching people in those moments. So is the research base guiding it ¹⁶. Your job isn't to fix this alone. It's to find the program that treats the step down from residential as the work, not the afterthought — and to let them carry the weight with you.

References

1. Oregon overdose deaths are down, CDC data shows. https://www.oregon.gov/oha/erd/pages/oregon-overdose-deaths-are-down-cdc-data-shows.aspx
2. Substance Use Disorder Integration Report. https://www.oregon.gov/oha/HSD/AMH/DataReports/SUD-Integration-Report.pdf
3. Substance Use Disorder 1115 Demonstration Waiver : Medicaid Policy. https://www.oregon.gov/oha/hsd/medicaid-policy/pages/sud-waiver.aspx
4. Oregon Health Plan 2021-2026 Substance Use Disorder 1115 Demonstration (Monitoring and Performance Assessment Report). https://www.ohsu.edu/sites/default/files/2024-10/SUD%20MPA%20Report%20Final.pdf
5. Substance Use Disorder Section 1115 Demonstration Opportunity. https://www.medicaid.gov/medicaid/section-1115-demonstrations/substance-use-disorder-section-1115-demonstration-opportunity
6. The Impacts of 1115 Medicaid Substance Use Disorder Waivers on Treatment Use and Health Outcomes. https://pmc.ncbi.nlm.nih.gov/articles/PMC12377293/
7. CDC Reports Nearly 24% Decline in U.S. Drug Overdose Deaths. https://www.cdc.gov/media/releases/2025/2025-cdc-reports-decline-in-us-drug-overdose-deaths.html
8. Drug Overdose Mortality | Stats of the States. https://www.cdc.gov/nchs/state-stats/deaths/drug-overdose.html
9. Oregon Heath Authority Behavioral Health Residential+ Facility Study. https://www.oregon.gov/oha/HSD/AMH/DataReports/Behavioral-Health-Residential-Facility-Study-June-2024.pdf
10. Measure 110 Lacks Stability, Coordination, and Clear Results. https://sos.oregon.gov/audits/Documents/2025-29.pdf
11. PSU Researchers Release Final Report in Landmark Project Exploring Impacts of Measure 110. https://www.pdx.edu/news/psu-researchers-release-final-report-landmark-project-exploring-impacts-measure-110
12. Behavioral Health Housing and Licensed Capacity Investments Dashboard. https://www.oregon.gov/oha/hsd/amh/pages/housing-dashboard.aspx
13. Behavioral Health Outpatient Treatment Programs. https://www.oregon.gov/oha/hsd/amh-lc/pages/op.aspx
14. Behavioral Health Resource Network (BHRN) Program. https://www.oregon.gov/oha/hsd/amh/pages/measure110.aspx
15. Oregon Health Authority : Reducing Opioid Overdose and Misuse. https://www.oregon.gov/oha/ph/preventionwellness/substanceuse/opioids/pages/index.aspx
16. Oregon Health Authority Strategic Plan (2024 – 2027). https://www.oregon.gov/oha/pages/strategic-plan.aspx
17. Patient Engagement in Providing Telehealth SUD Intensive Outpatient Program Treatment in Real-World Practice. https://pmc.ncbi.nlm.nih.gov/articles/PMC11675410/